Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients

Evans, 1994, Persistent giant cell arteritis despite corticosteroid treatment, Mayo Clin Proc, 69, 1060, 10.1016/S0025-6196(12)61373-1

Weyand, 1995, Giant cell arteritis as an antigen-driven disease, Rheum Dis Clin North Am, 21, 1027, 10.1016/S0889-857X(21)00483-X

Brack, 1997, Giant cell vasculitis is a T cell-dependent disease, Mol Med, 3, 530, 10.1007/BF03401699

Weyand, 2008, T cells in arteritis and atherosclerosis, Curr Opin Lipidol, 19, 469, 10.1097/MOL.0b013e32830bfdc2

Weyand, 2012, The immunopathology of giant cell arteritis: diagnostic and therapeutic implications, J Neuroophthalmol, 32, 259, 10.1097/WNO.0b013e318268aa9b

Hilhorst, 2014, T cell-macrophage interactions and granuloma formation in vasculitis, Front Immunol, 5, 432, 10.3389/fimmu.2014.00432

Deng, 2010, Th17 and Th1 T-cell responses in giant cell arteritis, Circulation, 121, 906, 10.1161/CIRCULATIONAHA.109.872903

McDonnell, 1986, Temporal arteritis. A clinicopathologic study, Ophthalmology, 93, 518, 10.1016/S0161-6420(86)33706-0

Ray-Chaudhuri, 2002, Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis, Br J Ophthalmol, 86, 530, 10.1136/bjo.86.5.530

Font, 2007, Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases, Br J Ophthalmol, 91, 204, 10.1136/bjo.2006.101725

Achkar, 1994, How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?, Ann Intern Med, 120, 987, 10.7326/0003-4819-120-12-199406150-00003

Weyand, 2014, Clinical practice. Giant-cell arteritis and polymyalgia rheumatica, N Engl J Med, 371, 50, 10.1056/NEJMcp1214825

Weyand, 2013, Immune mechanisms in medium and large-vessel vasculitis, Nat Rev Rheumatol, 9, 731, 10.1038/nrrheum.2013.161

Wagner, 1994, Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease, J Clin Invest, 94, 1134, 10.1172/JCI117428

Ma-Krupa, 2004, Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis, J Exp Med, 199, 173, 10.1084/jem.20030850

Wen, 2016, NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs, J Clin Invest, 126, 1953, 10.1172/JCI84181

Weyand, 2011, IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis, Curr Opin Rheumatol, 23, 43, 10.1097/BOR.0b013e32833ee946

Shirai, 2015, Macrophages in vascular inflammation—from atherosclerosis to vasculitis, Autoimmunity, 48, 139, 10.3109/08916934.2015.1027815

Weyand, 1996, Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis, J Clin Invest, 98, 1642, 10.1172/JCI118959

Rittner, 1999, Tissue-destructive macrophages in giant cell arteritis, Circ Res, 84, 1050, 10.1161/01.RES.84.9.1050

Pryshchep, 2008, Vessel-specific Toll-like receptor profiles in human medium and large arteries, Circulation, 118, 1276, 10.1161/CIRCULATIONAHA.108.789172